Universal-Beteiligungs- und Servicegesellschaft
LGND icon

Universal-Beteiligungs- und Servicegesellschaft’s Ligand Pharmaceuticals LGND Stock Holding History

Universal-Beteiligungs- und Servicegesellschaft’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.7M Buy
33,851
+8,611
+34% +$2.03M 0.02% 630
2026
Q1 		$5.04M Buy
25,240
+4,338
+21% +$858K 0.01% 865
2025
Q4 		$3.95M Sell
20,902
-934
-4% -$179K 0.01% 991
2025
Q3 		$3.87M Sell
21,836
-986
-4% -$147K 0.01% 989
2025
Q2 		$2.59M Buy
22,822
+1,736
+8% +$186K ﹤0.01% 1102
2025
Q1 		$2.22M Buy
+21,086
New +$2.38M ﹤0.01% 1145

Other funds holding LGND

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return

Universal-Beteiligungs- und Servicegesellschaft's LGND Position: Q2 2026 in Review

Universal-Beteiligungs- und Servicegesellschaft increased its Ligand Pharmaceuticals (LGND) stake by 34% in Q2 2026, buying an estimated $2.03M and bringing the position to 33,851 shares worth $10.7M. The position accounts for 0.02% of the portfolio, ranked #630.

Universal-Beteiligungs- und Servicegesellschaft first reported a position in LGND in Q1 2025 and has held it in 6 quarters since. 302 funds tracked by Wall St. Rank hold LGND as of Q2 2026.

  • Universal-Beteiligungs- und Servicegesellschaft held 33,851 shares of Ligand Pharmaceuticals worth $10.7M as of Q2 2026.
  • Universal-Beteiligungs- und Servicegesellschaft bought 8,611 Ligand Pharmaceuticals shares in Q2 2026, an estimated $2.03M.
  • Ligand Pharmaceuticals made up 0.02% of Universal-Beteiligungs- und Servicegesellschaft's portfolio in Q2 2026, its #630 holding.
  • Universal-Beteiligungs- und Servicegesellschaft first reported a position in Ligand Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
  • 302 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q2 2026.

Based on Universal-Beteiligungs- und Servicegesellschaft's 13F filing for Q2 2026, filed 6 Aug 2026.